Genomics Revolution
- NOTOC**
Genomics Revolution
The genomics revolution transformed biology from the study of individual genes into the large-scale investigation of complete genomes, gene regulation, genetic variation and interactions among DNA, cells, organisms and environments. Its symbolic beginning was the Human Genome Project, which produced the first broadly usable human reference genome and created technologies, computational methods and data-sharing practices that reshaped biomedical science. The landmark draft human genome sequences published in 2001 were followed by a substantially finished euchromatic reference in 2004. Subsequent advances have continued to fill previously unresolved regions and produce increasingly complete representations of human genomic diversity.
The revolution has been driven by a dramatic increase in sequencing capacity. Technologies that once required years and enormous resources to sequence a genome evolved into massively parallel systems capable of sequencing millions or billions of DNA fragments simultaneously. Next-generation sequencing enabled population genomics, cancer sequencing, transcriptomics, pathogen surveillance and large-scale studies of genetic variation. More recent long-read and single-molecule sequencing technologies have made it possible to reconstruct complex genomic regions, structural variants and nearly complete chromosomes that were difficult or impossible to resolve with short reads.
Genomics has consequently become a foundation of modern medicine, evolutionary biology, microbiology, agriculture, conservation and biotechnology. Massive genomic datasets are now combined with electronic health records, imaging, molecular measurements and artificial intelligence. At the same time, the ability to collect, analyze, share and modify genomic information has created substantial questions involving privacy, consent, equity, representation and governance.
From the Human Genome Project to Complete Genomes
The Human Genome Project established the technological and conceptual infrastructure for modern genomics. Its international sequencing effort produced a reference sequence that allowed researchers to systematically locate genes, compare genomes and investigate variation at unprecedented scale.
The first major draft human genome sequences were published in 2001 by the International Human Genome Sequencing Consortium and Celera Genomics. These projects demonstrated both large collaborative hierarchical sequencing and whole-genome shotgun approaches. The public project subsequently improved the sequence until approximately 99 percent of the euchromatic genome had been covered at high accuracy.
The Human Genome Project did far more than produce a DNA sequence. It stimulated improvements in sequencing chemistry, automation, computational genome assembly and publicly accessible biological databases. It also helped establish expectations that genomic data generated by large public research projects should be rapidly shared.
After the original project, researchers increasingly confronted the portions of the genome that remained difficult to sequence. Highly repetitive DNA, centromeres and other structurally complex regions were poorly represented in conventional references. Long-read sequencing and improved genome assembly eventually made it possible to resolve many of these regions and move toward telomere-to-telomere chromosome assemblies.
The concept of a single definitive human reference genome has also been challenged. Because humans contain extensive genetic and structural variation, one linear genome cannot adequately represent the entire species. This realization has encouraged the development of human pangenomes composed of multiple high-quality genome assemblies representing different haplotypes and populations.
The Sequencing Technology Revolution
Sequencing technology is one of the principal forces behind the genomics revolution. Early genomic research depended heavily on Sanger sequencing, which generated accurate but relatively limited amounts of DNA sequence. Massively parallel next-generation sequencing changed the scale of biological research by allowing enormous numbers of DNA fragments to be read simultaneously.
The falling cost and increasing throughput of sequencing made whole-genome, exome and transcriptome studies practical for large numbers of individuals. Researchers could begin examining millions of genetic variants across populations, sequencing thousands of tumors and studying the genetic diversity of microbial communities without first culturing the organisms involved.
Short-read sequencing remains extremely useful, but its limitations became apparent in repetitive and structurally complex regions. Long-read sequencing addressed many of these problems by generating DNA reads thousands or even tens of thousands of bases long. These technologies improve genome assembly and detection of deletions, duplications, inversions and other structural variants.
Single-molecule sequencing has expanded beyond basic genome assembly. It can now contribute to transcriptomics, epigenomics, targeted sequencing and direct investigation of molecular modifications and gene regulation.
As sequencing itself becomes faster and less expensive, computational analysis increasingly represents a major bottleneck. Genome assembly, alignment, annotation, variant calling, storage and interpretation require sophisticated algorithms and substantial computing infrastructure.
Human Genetic Variation and the Rise of Pangenomes
Large-scale genomics revealed that human genetic diversity is far more complex than a collection of isolated single-nucleotide differences. Human genomes contain millions of single-nucleotide variants as well as insertions, deletions, duplications, inversions and other structural changes.
The International HapMap Project catalogued common patterns of human genetic variation and provided essential infrastructure for early genome-wide association studies. The 1000 Genomes Project expanded this effort through population-scale sequencing and ultimately documented tens of millions of variants among thousands of individuals from populations around the world.
Resources such as the Genome Aggregation Database further increased the scale of population genetics by combining genomic data from more than 100,000 people. Such datasets make it possible to determine how frequently variants occur and identify genes unusually intolerant of disruptive mutations.
Structural variation has become increasingly important as sequencing improves. Large deletions, duplications, inversions and rearrangements can alter gene dosage, disrupt regulatory regions and contribute significantly to human diversity and disease.
The human pangenome represents an important conceptual change. Instead of treating one genome sequence as the universal reference, pangenome projects incorporate multiple complete or near-complete genomes. This reduces reference bias and improves the detection of genomic variation across diverse human populations.
Functional Genomics, Epigenomics and Gene Regulation
Sequencing a genome reveals its DNA sequence, but understanding how that genome functions requires determining when genes are active, how regulatory regions operate and how genome organization varies among cell types.
The ENCODE Project systematically mapped transcription, transcription-factor binding, chromatin accessibility and other biochemical features across the human genome. The Roadmap Epigenomics Project produced reference epigenomes representing many human tissues and cell types.
These efforts demonstrated that biological function extends far beyond protein-coding genes. Enhancers, promoters, chromatin states, non-coding RNAs and three-dimensional chromosome organization all contribute to gene regulation.
RNA sequencing became one of the most important tools in functional genomics. RNA-seq permits genome-wide measurement of gene expression and reveals alternative splicing, previously unknown transcripts and differences in transcription across tissues, developmental stages and disease states.
The GTEx project connected genetic variation with gene expression across many human tissues. These data help researchers understand how inherited variants influence the activity of genes and how regulatory variation contributes to traits and diseases.
Three-dimensional genomics added another dimension to gene regulation. Technologies such as Hi-C revealed that chromosomes are organized into loops, domains, compartments and territories. Regulatory interactions can therefore involve genomic regions that are widely separated in the linear DNA sequence but positioned close together within the nucleus.
Single-Cell and Spatial Genomics
Traditional genomic experiments often analyze DNA or RNA from millions of cells together. Such measurements provide useful averages but can obscure important differences among individual cells.
Single-cell sequencing changed this by making it possible to measure genomes, transcriptomes and epigenomes one cell at a time. Researchers can identify previously unknown cell types, distinguish cellular states and investigate how genetic variation affects specific populations of cells.
Single-cell genomics has become particularly valuable in cancer research, developmental biology, neuroscience, immunology and studies of genetic mosaicism. Tumors, for example, may contain multiple genetically and transcriptionally distinct cell populations with different biological behaviors.
The Human Cell Atlas extends this approach toward systematically characterizing the cells that make up the human body.
Spatial genomics adds information about where cells and molecules are physically located within tissues. Spatial transcriptomics and related technologies preserve tissue architecture while measuring RNA, proteins and other molecular features. These methods reveal cellular neighborhoods, developmental patterns and interactions among neighboring cells.
Multi-omic technologies increasingly measure several types of molecular information simultaneously. Genome sequence, chromatin accessibility, gene expression, proteins and spatial position can be combined to create increasingly detailed models of cellular biology.
Genome-Wide Association Studies and Complex Traits
Genome-wide association studies transformed the investigation of common diseases and complex traits. Instead of examining one candidate gene at a time, GWAS scans large portions of the genome for variants associated with measurable characteristics or disease risk.
Thousands of studies have linked genetic variants with conditions and traits involving cardiovascular disease, diabetes, autoimmune disorders, height, metabolism and many other biological characteristics.
Most common traits are influenced by large numbers of variants, each contributing a relatively small effect. Polygenic risk scores attempt to combine these effects into a single estimate of genetic susceptibility.
Polygenic scores may eventually contribute to disease prediction and preventive medicine, but their interpretation remains difficult. Their accuracy depends heavily on the populations represented in the datasets used to create them.
The historical overrepresentation of people of European ancestry in genomic research can reduce the accuracy of genetic predictions in other populations. Increasing genomic diversity has therefore become both a scientific and an equity priority.
Genomic Medicine and Rare-Disease Diagnosis
Genomic medicine seeks to use genome-scale information in clinical diagnosis, prevention and treatment. One of its clearest successes has been the diagnosis of rare genetic disorders.
Many rare diseases are caused by mutations in single genes. Before widespread sequencing, patients and families could spend years undergoing repeated medical tests without receiving a diagnosis. Exome sequencing and whole-genome sequencing made it possible to examine thousands of genes simultaneously.
Whole-genome sequencing can detect variants that exome sequencing or targeted tests may miss, particularly changes involving structural variation, non-coding regions and difficult genomic sequences. Long-read sequencing may further increase diagnostic capabilities by identifying complex variants that conventional methods cannot easily resolve.
Interpreting genetic variants remains one of the central challenges of genomic medicine. The ACMG and AMP classification framework established widely used categories such as pathogenic, likely pathogenic, uncertain significance, likely benign and benign.
Large population databases, family information, computational predictions and experimental evidence are often combined to determine whether a variant is clinically meaningful.
Newborn Genomics and Prenatal Testing
Sequencing is increasingly being considered for newborn screening. Traditional newborn screening identifies a limited set of serious and treatable disorders using biochemical tests. Genomic sequencing could potentially detect a much larger number of genetic conditions before symptoms appear.
Rapid genome sequencing has shown particular promise in neonatal intensive-care settings, where critically ill infants may have undiagnosed genetic disorders. Fast identification of the underlying condition can sometimes alter treatment and clinical management.
Prenatal genomics has expanded through cell-free fetal DNA analysis and sequencing-based diagnostic methods. Non-invasive prenatal screening initially focused on chromosome abnormalities but is increasingly being investigated for broader genomic applications.
These technologies also raise questions about which conditions should be screened for, how uncertain results should be communicated and how parents should make decisions about genomic information whose implications may not be fully understood.
Pharmacogenomics and Personalized Treatment
Pharmacogenomics examines how genetic variation affects individual responses to medications. Some variants influence drug metabolism, therapeutic effectiveness or the probability of adverse reactions.
Genomic information can therefore potentially help clinicians choose medications or doses that are better suited to individual patients.
Pharmacogenomics represents one of the earliest practical applications of personalized genomic medicine. Its clinical implementation is expanding, although healthcare systems must address testing infrastructure, interpretation, physician education and integration with electronic health records.
Cancer Genomics
Cancer is fundamentally a genomic disease involving genetic and epigenetic changes that allow cells to grow, survive and spread abnormally.
Projects such as The Cancer Genome Atlas and the Pan-Cancer Analysis of Whole Genomes have systematically characterized tumors across numerous cancer types. These studies revealed recurrent mutations, structural rearrangements, altered regulatory pathways and molecular similarities among cancers arising in different organs.
Tumor sequencing increasingly influences clinical oncology. Molecular profiles can help classify tumors, identify actionable mutations and guide targeted therapies.
Cancer genomic analysis may use targeted gene panels, exome sequencing, whole-genome sequencing and transcriptome analysis. Germline testing may also identify inherited cancer susceptibility affecting patients and their relatives.
Population Genomics and Biobanks
Population-scale genomics links genetic information with medical, behavioral and environmental data from large numbers of individuals.
The UK Biobank combines genetic information with health records, imaging, biomarkers and lifestyle information from hundreds of thousands of participants. Whole-genome and exome sequencing within this cohort has created one of the world's largest resources for studying relationships between genetic variation and human traits.
The United States All of Us Research Program similarly seeks to connect genomic data with electronic health records, surveys and biological samples at very large scale.
Population genomics increasingly emphasizes representation. African populations contain exceptionally high levels of human genetic diversity but have historically been underrepresented in major genomic databases. Broader inclusion can reveal previously unknown variants, improve understanding of human evolutionary history and make genomic medicine more equitable.
Ancient DNA and Human Evolution
Ancient DNA transformed the study of human evolution by allowing researchers to obtain genomic information directly from people and other organisms that lived hundreds or thousands of years ago.
Ancient genomes provide evidence about migrations, population replacement, admixture and natural selection that cannot be reconstructed from modern populations alone.
Genome sequencing revealed that modern humans interbred with Neanderthals and other archaic human groups. Ancient DNA has also provided increasingly detailed information about prehistoric migrations and the spread of agriculture, languages and cultural practices.
Researchers can track changes in allele frequencies through time and investigate adaptation to diet, climate, infectious disease and other selective pressures.
Ancient genomics is increasingly being used to examine social organization. Genetic relationships among individuals buried at archaeological sites can provide clues about kinship, marriage patterns, migration and community structure.
Ancient DNA research nevertheless presents significant technical challenges because DNA degrades over time and samples are vulnerable to modern contamination.
Pathogen Genomics and Genomic Surveillance
Sequencing has become a powerful tool for monitoring infectious disease.
Whole-genome sequencing can distinguish closely related strains of bacteria and viruses, allowing epidemiologists to reconstruct transmission chains, identify outbreaks and monitor the emergence of antimicrobial resistance.
The World Health Organization has promoted global genomic-surveillance capacity for pathogens with epidemic and pandemic potential.
Portable sequencing technologies make genomic surveillance increasingly feasible outside centralized laboratories. During outbreaks, genomic information can sometimes be generated close to where infections occur.
Genomic surveillance is also increasingly used in hospitals to investigate healthcare-associated infections and determine whether apparently separate cases are part of the same transmission network.
Metagenomics and the Human Microbiome
Traditional microbiology depends heavily on growing microorganisms in laboratory culture. Many microbes, however, are difficult or impossible to culture using conventional methods.
Metagenomics bypasses this limitation by sequencing genetic material directly from environmental or biological samples. Researchers can therefore study entire microbial communities without isolating every organism individually.
Metagenomics transformed understanding of the human microbiome. Large microbial communities inhabit the intestine, skin, mouth and other parts of the body.
Genomic studies investigate relationships between these microbial communities and digestion, immune function, metabolism, infectious disease and other aspects of health.
Clinical metagenomic sequencing also offers a potential method for diagnosing infections without specifying the suspected organism beforehand. DNA or RNA from pathogens can sometimes be detected directly from patient samples.
Antibiotic Resistance Genomics
Genomic analysis has become central to understanding antimicrobial resistance.
Resistance genes exist not only in disease-causing bacteria but also throughout microbial communities and environmental reservoirs. The collective pool of resistance genes is often described as the resistome.
Whole-genome and metagenomic sequencing allow researchers to track resistance genes, identify emerging bacterial lineages and reconstruct their spread across hospitals, communities, food-production systems and international borders.
Genomic surveillance therefore contributes to both clinical infection control and broader efforts to understand the evolutionary ecology of antimicrobial resistance.
Genome Editing and CRISPR
The genomics revolution moved from reading DNA toward deliberately modifying it.
CRISPR-Cas systems provided researchers with programmable tools for targeting specific DNA sequences. CRISPR-based technologies can disable genes, alter regulatory regions and perform large-scale functional screens involving thousands of genetic targets.
Newer approaches such as base editing and prime editing make increasingly precise sequence modifications possible without relying entirely on conventional double-strand DNA breaks.
Genome editing has enormous potential in biological research and medicine. It may eventually contribute to treatments for inherited disease, cancer and other disorders.
The same capabilities create difficult safety and ethical questions, particularly when modifications could affect reproductive cells and future generations.
Artificial Intelligence and Computational Genomics
Modern genomics generates datasets too large and complex to interpret manually. Machine learning and artificial intelligence have therefore become increasingly important.
AI systems can analyze genome sequences, predict functional effects of genetic variants, identify regulatory patterns and integrate genomic information with clinical data.
Deep-learning methods can detect patterns that may be difficult to identify using conventional statistical methods. Explainable AI attempts to determine which genomic features are responsible for algorithmic predictions and connect those predictions with biological mechanisms.
Artificial intelligence is also being applied to genome editing. Computational models can help identify CRISPR targets, predict off-target effects and improve the design of nuclease, base-editing and prime-editing systems.
AI may also help integrate genomic information with longitudinal electronic health records, enabling more sophisticated approaches to disease prediction and biomedical discovery.
Comparative and Evolutionary Genomics
Comparative genomics examines similarities and differences among genomes from different species.
Genome comparisons can identify conserved sequences that have remained relatively unchanged through evolution, suggesting important biological functions. They can also reveal genes and regulatory regions associated with adaptations unique to particular lineages.
Comparative genomic studies contribute to understanding speciation, reproductive isolation, gene flow and genome evolution.
Phylogenetic relationships must be incorporated carefully because closely related species share genetic similarities partly because of common ancestry. Modern comparative genomics therefore integrates evolutionary models with large genomic datasets.
Conservation Genomics
Genomic technologies increasingly contribute to biodiversity conservation.
Conservation genomics can measure genetic diversity, population structure, inbreeding and migration among threatened populations. This information can help conservation managers determine which populations require genetic rescue or greater connectivity.
Genomic information can also help guide ecological restoration. Seed sourcing and population management may be informed by genetic diversity and evidence about adaptation to local environments.
Natural-history museums and other biological collections contain preserved specimens representing vast numbers of species. Improvements in DNA recovery and sequencing increasingly allow these collections to become genomic archives documenting biodiversity across both geography and time.
Genome engineering has also been proposed as a conservation tool, although potential ecological consequences and governance concerns require careful evaluation.
Agricultural Genomics
Genomics transformed plant and animal breeding.
Crop genomes, resequencing projects and genome-wide markers allow researchers to locate genetic variants associated with productivity, disease resistance, environmental tolerance and other agriculturally valuable traits.
Plant pangenomes reveal genetic variation absent from individual reference genomes and provide new resources for crop improvement and domestication research.
Livestock breeding increasingly uses genomic selection. Instead of waiting for traits to appear in mature animals or their offspring, breeders can use genome-wide markers to estimate breeding value earlier.
Multi-omics approaches may further integrate genomics with gene expression, epigenetics, metabolism and other biological information to improve agricultural selection.
Synthetic Genomics and Synthetic Biology
Synthetic biology uses engineering principles to construct or redesign biological systems.
Early synthetic-biology research developed engineered genetic circuits that could switch genes on and off, respond to signals and perform relatively simple biological functions.
Synthetic genomics extends these ideas toward larger-scale manipulation and construction of genomes. Researchers are developing approaches for designing, assembling, delivering and debugging increasingly large synthetic DNA systems.
Potential applications include biological manufacturing, engineered cells, diagnostics, therapeutics, agriculture and environmental biotechnology.
Synthetic genomics also provides an experimental approach for understanding fundamental biological principles. Building biological systems can reveal which components are necessary for particular functions and how genetic networks behave.
Genomic Data, Cloud Computing and Bioinformatics
The scale of genomic information has created enormous computational demands.
Genome projects produce large datasets requiring substantial storage, processing and high-performance computing. Cloud computing allows research groups to analyze large genomic resources without maintaining all necessary infrastructure locally.
Bioinformatics methods are required throughout the genomic workflow, including sequence alignment, assembly, variant detection, genome annotation and statistical analysis.
As datasets grow, interoperability and data sharing become increasingly important. Large genomic projects often involve international collaborations in which researchers must analyze enormous datasets across institutions and computing environments.
Computational capacity has therefore become as fundamental to genomics as laboratory sequencing technology.
Genomic Privacy, Ethics and Equity
Genomic information is unusually sensitive because DNA can reveal information not only about an individual but also about biological relatives.
Large-scale genomic databases create opportunities for scientific discovery while introducing risks involving privacy, informed consent, data security and potential re-identification.
Genomic data may remain informative for a lifetime. Unlike passwords or financial identifiers, an individual's genome cannot simply be replaced after a privacy breach.
Researchers and policymakers have therefore developed increasingly sophisticated approaches to genomic governance, including controlled access, privacy-preserving computation and frameworks governing responsible data sharing.
Equity is another central challenge. Populations underrepresented in genomic research may receive fewer benefits from genomic discoveries, while genetic prediction tools developed primarily from one ancestry group may perform poorly in others.
Global genomic research therefore increasingly emphasizes representation, equitable access and fair distribution of scientific and medical benefits.
The Expanding Meaning of Genomics
The meaning of genomics has expanded far beyond sequencing complete genomes.
Modern genomics includes transcriptomics, epigenomics, spatial genomics, single-cell biology, metagenomics, population genetics, evolutionary analysis, genomic medicine and increasingly complex multi-omic approaches.
The field is moving from static descriptions of DNA sequence toward integrated models explaining how genomes operate within cells, tissues, organisms, populations and ecosystems.
Genomics is also increasingly connected with artificial intelligence, electronic health records, environmental data and large-scale biological databases.
The resulting picture of biology is simultaneously more precise and more complex. Genes operate through regulatory networks, cellular environments, developmental processes and interactions with other organisms and environments.
Conclusion
The genomics revolution is one of the most consequential transformations in modern biological science. The Human Genome Project established a foundational reference and stimulated technologies that made large-scale DNA sequencing possible. Next-generation and long-read sequencing then expanded genomic research from single genomes to millions of variants, thousands of organisms and increasingly complete representations of biological diversity.
Genomics now influences rare-disease diagnosis, cancer treatment, pharmacogenomics, newborn medicine, pathogen surveillance, human evolution, agriculture, conservation and biotechnology. Single-cell and spatial technologies are revealing how genomes operate within individual cells and tissues, while pangenomes are replacing the idea that one reference genome can adequately represent an entire species.
Artificial intelligence and increasingly powerful computational systems are becoming essential for interpreting genomic information. Genome editing has simultaneously transformed genomics from a primarily observational science into one capable of directly manipulating biological systems.
These advances also create profound responsibilities. Questions involving privacy, consent, representation, equity, reproductive intervention and genomic-data governance will shape how genomic technologies are used.
The genomics revolution is therefore not simply a technological transition. It represents a fundamental change in how scientists understand biological variation, disease, evolution and the relationship between genetic information and living systems. As sequencing, computation and genome engineering continue to advance, genomics is likely to become an increasingly integrated foundation for biology, medicine and environmental science.
- TOC**
Foundations of the Genomics Revolution
| National Human Genome Research Institute | NHGRI | 2026
Overview of the Human Genome Project, its international organization, accomplishments, data-sharing principles, technological legacy, and effects on biomedical research.
| National Human Genome Research Institute | NHGRI | 2026
Explains the Human Genome Project and how its 1990–2003 effort created the first reference sequence of the human genome and transformed biomedical science.
Explains how long-read sequencing and new computational tools enabled researchers to resolve genomic regions missing from the original Human Genome Project reference.
| National Human Genome Research Institute | NHGRI | 2021
Reviews the twentieth anniversary of the landmark 2001 human-genome papers and their role in launching modern genomic medicine and large-scale DNA sequencing.
| Eric D. Green et al. | Nature | 2020
NHGRI's strategic vision describes the next phase of genomics, including technology development, genomic medicine, diversity, implementation, and societal implications.
| Eric D. Green, Mark S. Guyer and NHGRI | Nature | 2011
Charts the transition from obtaining genome sequences to understanding genome biology and applying genomic discoveries at the bedside.
| International Human Genome Sequencing Consortium | Nature | 2004
Describes the finishing of approximately 99% of the euchromatic human genome and the dramatic improvement in sequence accuracy after the original draft.
| Francis S. Collins et al. | Nature | 2003
A post-Human Genome Project blueprint outlining how genome sequencing could lead to deeper biological understanding, disease research, and eventual applications in medicine.
| International Human Genome Sequencing Consortium | Nature | 2001
Landmark report of the first draft human genome sequence, establishing a foundational reference for modern genomics and opening a new era of genome-scale biological research.
| J. Craig Venter et al. | Science | 2001
Celera Genomics' landmark whole-genome shotgun analysis provided an independent draft of the human genome and demonstrated the growing power of computational genome assembly.
DNA Sequencing Technologies
| Authors listed in source | Molecular Biology Reports | 2025
Reviews high-throughput sequencing platforms and their rapidly expanding roles in whole-genome analysis, molecular diagnostics, personalized medicine, and infectious-disease preparedness.
| Peter E. Warburton and Robert P. Sebra | Annual Review of Genomics and Human Genetics | 2023
Reviews advances in long-read DNA sequencing and the remaining technological and analytical obstacles to fully resolving complex human genomes.
| Paul W. Hook and Winston Timp | Nature Reviews Genetics | 2023
Describes how single-molecule sequencing has expanded beyond genome assembly into transcriptomics, epigenomics, targeted sequencing, and studies of gene regulation.
Examines the emerging use of long-read sequencing across large populations and its ability to improve structural-variant discovery and genome assembly.
| Glennis A. Logsdon, Mitchell R. Vollger and Evan E. Eichler | Nature Reviews Genetics | 2020
Explains how long-read sequencing exposes structural variation, repetitive DNA, difficult genomic regions, and chromosome-scale assemblies that short reads frequently miss.
| Rangarajan Xian and colleagues | Methods in Molecular Biology | 2019
Surveys DNA-analysis technologies from Sanger sequencing and microarrays through next-generation and emerging single-molecule long-read sequencing systems.
| Fritz J. Sedlazeck et al. | Nature Reviews Genetics | 2018
Reviews the computational methods needed to analyze long-read sequencing and mapping technologies capable of penetrating previously inaccessible genomic regions.
| Sara Goodwin, John D. McPherson and W. Richard McCombie | Nature Reviews Genetics | 2016
Reviews the first decade of next-generation sequencing and the transition from early short-read systems toward increasingly capable long-read technologies.
| Elaine R. Mardis | Cell | 2013
Examines how massively parallel sequencing changed genomics from relatively small-scale genome studies into a discipline capable of investigating biology genome-wide.
| Michael L. Metzker | Nature Reviews Genetics | 2010
A major review of next-generation sequencing technologies explaining the platforms, chemistry, read generation, genome assembly, variant calling, costs, and emerging applications.
Human Genetic Variation, References and Pangenomes
| Wen-Wei Liao et al. | Nature | 2023
Introduces the draft human pangenome reference based on diverse phased genome assemblies, moving human genetics beyond reliance on a single linear reference genome.
| Telomere-to-Telomere Consortium and collaborators | Nature | 2023
Reports the first complete sequence of a human Y chromosome, adding more than 30 million bases missing from the conventional reference.
| Konrad J. Karczewski et al. | Nature | 2020
The gnomAD study uses variation from more than 140,000 people to quantify which human genes are unusually intolerant of potentially damaging mutations.
| Ryan L. Collins et al. | Nature | 2020
Establishes a large population reference for structural variants, revealing their extensive contribution to genomic diversity and potentially damaging genetic changes.
| Steve S. Ho, Alexander E. Urban and Ryan E. Mills | Nature Reviews Genetics | 2020
Reviews structural variation and how improved sequencing platforms are revealing deletions, duplications, inversions, translocations, and other genome-scale changes.
| 1000 Genomes Project Consortium | Nature | 2015
Final major 1000 Genomes Project report covering 2,504 individuals from 26 populations and more than 88 million identified genetic variants.
| 1000 Genomes Project Consortium | Nature | 2012
Describes genomic variation across 1,092 individuals and established an increasingly detailed reference for common and rare variants across global populations.
| 1000 Genomes Project Consortium | Nature | 2010
Reports the pilot phase of the 1000 Genomes Project, demonstrating population-scale sequencing strategies for cataloguing human genomic variation.
| International HapMap Consortium | Nature | 2007
The second-generation HapMap expanded the catalogue to more than three million SNPs and greatly strengthened the ability to study common disease-associated variants.
| International HapMap Consortium | Nature | 2005
The first International HapMap established a large public catalogue of common human genetic variation and provided critical infrastructure for genome-wide association studies.
Functional Genomics, Epigenomics and Single Cells
| Anna S. E. Cuomo et al. | Nature Reviews Genetics | 2023
Explores the convergence of population-scale human genetics with single-cell genomic data to determine how genetic variants act in specific cell types.
| ENCODE Project Consortium et al. | Nature | 2020
Expands ENCODE with thousands of experiments and a much larger catalogue of candidate regulatory elements in human and mouse genomes.
| Authors listed in source | Human Molecular Genetics | 2020
Reviews how single-cell genomic and epigenomic technologies are revealing cellular heterogeneity in cancer, diabetes, aging, and other complex diseases.
| Vivian Tam et al. | Nature Reviews Genetics | 2019
Reviews how genome-wide association studies transformed complex-disease genetics while also discussing interpretation, causality, ancestry bias, and other limitations.
| Orit Rozenblatt-Rosen et al. | Nature | 2017
Introduces the Human Cell Atlas effort to systematically characterize the cell types and molecular states that make up the human body.
| Charles Gawad, Winston Koh and Stephen R. Quake | Nature Reviews Genetics | 2016
Reviews methods and challenges in sequencing the genomes of individual cells and their applications in microbiology, cancer, development, and genetic mosaicism.
| Roadmap Epigenomics Consortium et al. | Nature | 2015
Integrates 111 reference human epigenomes and links tissue-specific regulatory states to genetic variants associated with human diseases and traits.
| Thierry Voet, Shamit S. S. et al. | PLOS Genetics | 2014
Surveys breakthroughs in single-cell genome and transcriptome amplification that made cellular-level genomic heterogeneity experimentally accessible.
| Ehud Shapiro, Tamir Biezuner and Sten Linnarsson | Nature Reviews Genetics | 2013
Anticipates how sequencing individual cells could transform understanding of cell types, development, lineage, disease, and organism-wide biology.
| ENCODE Project Consortium | Nature | 2012
The ENCODE Project maps transcription, transcription-factor binding, chromatin structure, and other biochemical features across the human genome.
Genomic Medicine and Rare-Disease Diagnosis
| Manjunath Dammalli et al. | Expert Review of Molecular Diagnostics | 2026
Reviews genomic diagnostics as a central component of precision medicine, including sequencing workflows, bioinformatics, clinical interpretation, and implementation.
| Tessa J. J. de Bitter et al. | New England Journal of Medicine | 2026
Reports clinical testing of long-read genome sequencing in patients with rare genetic disease and compares its diagnostic yield with standard approaches.
| Kristen M. Wigby et al. | npj Genomic Medicine | 2024
Reviews evidence for using whole-genome sequencing as an early or first-line diagnostic test in patients suspected of having rare genetic disorders.
| Euan A. Ashley | Nature Reviews Genetics | 2016
Examines how sequencing, improved variant interpretation, data sharing, and clinical standards can move medicine toward more precise diagnosis and treatment.
| Authors listed in source | Genetics in Medicine | 2016
Discusses the opportunities and practical barriers involved in moving genome and exome sequencing from specialized settings into everyday medicine.
| H. Stranneheim and A. Wedell | Journal of Internal Medicine | 2016
Reviews how exome and genome sequencing transformed identification and diagnosis of monogenic diseases.
| Orli Bahcall | Nature | 2015
Introduces major precision-medicine developments linking genomic information to pharmacogenomics, targeted treatments, clinical trials, and population-scale sequencing.
| Kym M. Boycott et al. | Nature Reviews Genetics | 2013
Explains how next-generation sequencing accelerated discovery of genes causing rare diseases and shortened the diagnostic odyssey for affected families.
Updates clinicians on rapid genomic advances following the Human Genome Project and the emerging transition from genetic medicine to genomic medicine.
| Alan E. Guttmacher and Francis S. Collins | New England Journal of Medicine | 2002
Early clinical primer explaining how the emerging genome era could move medicine beyond traditional single-gene genetics toward genome-scale approaches.
Newborn Genomics, Pharmacogenomics and Cancer
| Anastasia L. Gant Kanegusuku et al. | Critical Reviews in Clinical Laboratory Sciences | 2024
Reviews strategies for implementing pharmacogenomic testing in hospitals and other clinical settings.
| Authors listed in source | Molecular Aspects of Medicine | 2024
Surveys sequencing technologies used in precision cancer medicine, from targeted panels to whole-genome and transcriptome sequencing.
| Zornitza Stark and Richard H. Scott | Nature Reviews Genetics | 2023
Reviews efforts to incorporate genomic sequencing into newborn screening for early detection of treatable rare disorders.
| Alissa M. D'Gama and Pankaj B. Agrawal | European Journal of Human Genetics | 2023
Examines the growing use of rapid genome sequencing and genomic medicine in neonatal intensive care and other newborn settings.
| Munir Pirmohamed | Nature Reviews Genetics | 2023
Reviews the current state of pharmacogenomics and efforts to use genetic variation to improve medication efficacy, safety, and prescribing.
| Debyani Chakravarty and David B. Solit | Nature Reviews Genetics | 2021
Reviews the integration of tumor genomic profiling into routine oncology for diagnosis, targeted therapy selection, and hereditary cancer assessment.
| ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium | Nature | 2020
Integrates 2,658 whole cancer genomes across 38 tumor types to reveal genomic drivers and patterns shared across cancers.
| Chandan Kumar-Sinha and Arul M. Chinnaiyan | Nature Biotechnology | 2018
Explains how genomic and transcriptomic tumor profiling supports increasingly individualized approaches to cancer diagnosis and treatment.
| Richard M. Weinshilboum and Liewei Wang | Mayo Clinic Proceedings | 2017
Traces the development of pharmacogenomics and its emergence as one of the first major clinical applications of personalized genomic medicine.
| Cancer Genome Atlas Research Network et al. | Nature Genetics | 2013
Describes The Cancer Genome Atlas Pan-Cancer project and its integrated molecular analysis of cancers across different tissues.
Population Genomics, Biobanks and Diversity
| National Institutes of Health | NIH | 2026
Reports the expansion of All of Us into an enormous integrated genomic and health database containing hundreds of thousands of whole-genome sequences.
| AGenDA investigators and collaborators | Nature | 2026
Describes efforts to sequence underrepresented African populations and capture genomic diversity poorly represented in existing international databases.
| UK Biobank Whole-Genome Sequencing Consortium | Nature | 2025
Describes whole-genome sequencing of nearly 491,000 UK Biobank participants, creating one of the world's largest population genomic resources.
| All of Us Research Program Genomics Investigators | Nature | 2024
Describes genomic data from 245,388 All of Us participants and reports hundreds of millions of variants, including many previously unreported variants.
| Bjarni V. Halldorsson et al. | Nature | 2022
Reports whole-genome sequences for more than 150,000 UK Biobank participants and hundreds of millions of genetic variants.
| Szilard Szustakowski et al. | Nature | 2021
Analyzes exome sequences from more than 450,000 UK Biobank participants to link protein-altering variants with thousands of human traits.
| Amy R. Bentley, Shawneequa L. Callier and Charles N. Rotimi | npj Genomic Medicine | 2020
Examines the scientific and medical benefits of increasing representation of African-ancestry populations in genomic research.
| All of Us Research Program Investigators | New England Journal of Medicine | 2019
Describes the design and goals of the million-person All of Us cohort linking genomics with electronic health records, surveys, biospecimens, and other data.
| Clare Bycroft et al. | Nature | 2018
Introduces the UK Biobank as a deeply phenotyped population resource combining genetic data with extensive health, lifestyle, imaging, and biomarker information.
| Noah A. Rosenberg et al. | Nature Reviews Genetics | 2010
Reviews genome-wide association studies across diverse populations and explains why ancestry diversity is essential for accurate genetic discovery.
Ancient DNA and Human Evolution
| Dina MemarMoshrefi, Olivia L. Johnson and Christian D. Huber | Nature Genetics | 2026
Reviews how rapidly expanding ancient-genome datasets reveal human adaptation and changes in allele frequencies across thousands of years.
| David Reich and collaborators | Nature | 2026
Uses large ancient-DNA datasets to identify long-term directional natural selection across West Eurasian populations.
| Anders Bergström et al. | Nature | 2021
Reviews how palaeoanthropological discoveries and genomic evidence have reshaped understanding of modern human ancestry and interactions among ancient populations.
| Fernando Racimo et al. | Nature Reviews Genetics | 2020
Examines how ancient genomes are increasingly revealing local social organization, migration, inheritance, marriage patterns, and cultural change.
| Stephanie Marciniak and George H. Perry | Nature Reviews Genetics | 2017
Explains how ancient genomes can directly track human adaptation to climate, diet, agriculture, disease, and interactions with archaic humans.
| Ludovic Orlando, M. Thomas P. Gilbert and Eske Willerslev | Nature Reviews Genetics | 2015
Reviews the sequencing technologies and computational approaches that made reconstruction of ancient genomes and epigenomes possible.
| Joshua G. Schraiber and Joshua M. Akey | Nature Reviews Genetics | 2015
Reviews computational approaches for reconstructing human evolutionary history from large genomic datasets.
| Mark Stoneking and Johannes Krause | Nature Reviews Genetics | 2011
Shows how genome-scale data from ancient and modern humans transformed reconstruction of migrations, population relationships, admixture, and demographic history.
| L. Luca Cavalli-Sforza and Marcus W. Feldman | Nature Genetics | 2003
Reviews early molecular-genetic approaches that laid the groundwork for genome-scale reconstruction of human evolution and population history.
| Michael Hofreiter et al. | Nature Reviews Genetics | 2001
Early review of ancient-DNA research, contamination problems, DNA preservation, and the possibilities for recovering genetic information from historical remains.
Pathogen Genomics, Metagenomics and the Microbiome
| Mary K. Hayden, Sarah E. Sansom and Evan S. Snitkin | Nature Reviews Microbiology | 2026
Reviews use of whole-genome sequencing to detect transmission and help prevent bacterial infections acquired in healthcare settings.
| Pamela Ferretti et al. | Nature Reviews Genetics | 2026
Reviews genomic approaches for understanding two-way interactions between the human genome and the microbiome.
| Kirstyn Brunker | Nature Reviews Genetics | 2024
Highlights portable and field-ready sequencing approaches that can make genomic pathogen surveillance more accessible during outbreaks.
| World Health Organization | WHO | 2022
Presents WHO's global strategy for building genomic surveillance capacity for pathogens with epidemic and pandemic potential.
| Marta Gwinn, Duncan MacCannell and Gregory L. Armstrong | JAMA | 2019
Reviews how next-generation sequencing is changing pathogen identification, outbreak investigation, antimicrobial resistance tracking, and public-health surveillance.
| Maria A. Spyrou et al. | Nature Reviews Genetics | 2019
Explains how ancient pathogen genomes reveal the emergence, spread, evolution, and disappearance of infectious-disease lineages.
| Jennifer L. Gardy and Nicholas J. Loman | Nature Reviews Genetics | 2018
Describes the potential for sequencing and digital epidemiology to create a real-time global pathogen surveillance system.
| Jack A. Gilbert et al. | Nature Medicine | 2018
Reviews how genomic sequencing transformed understanding of the human microbiome and its relationships with health and disease.
| Eric A. Franzosa et al. | Nature Reviews Microbiology | 2015
Reviews integration of metagenomics, transcriptomics, proteomics, and related molecular approaches for understanding microbial communities.
| Susannah Green Tringe and Edward M. Rubin | Nature Reviews Genetics | 2005
Foundational review of metagenomics and the use of DNA sequencing to investigate microbial communities that cannot readily be cultured.
Genome Editing, Artificial Intelligence and Genomic Ethics
| Peter J. Chen and David R. Liu | Nature Reviews Genetics | 2023
Reviews prime editing, which permits precise genomic substitutions, insertions, and deletions without requiring conventional double-strand DNA breaks.
| Gherman Novakovsky et al. | Nature Reviews Genetics | 2023
Reviews explainable artificial intelligence approaches designed to uncover biological mechanisms underlying deep-learning predictions in genomics.
| Laralynne Przybyla and Luke A. Gilbert | Nature Reviews Genetics | 2022
Examines how CRISPR technologies are creating a new era of scalable functional-genomics experiments targeting genes and regulatory elements.
| Jennifer A. Doudna | Nature | 2020
Reviews the therapeutic promise of CRISPR genome editing alongside technical, safety, ethical, and societal challenges.
| Luca Bonomi, Yingxiang Huang and Lucila Ohno-Machado | Nature Genetics | 2020
Reviews privacy risks created by genomic data sharing and technical approaches for protecting individuals while enabling biomedical discovery.
| James Brian Byrd et al. | Nature Reviews Genetics | 2020
Examines practical and ethical approaches to genomic-data sharing that preserve participant privacy while supporting reproducible and collaborative science.
| Shawneequa L. Callier et al. | Bioethics | 2016
Reviews ethical, legal, and social issues surrounding personalized genomic medicine, including privacy, consent, research participation, and communication of genomic information.
| Ophir Shalem, Neville E. Sanjana and Feng Zhang | Nature Reviews Genetics | 2015
Reviews how CRISPR-Cas9 enabled high-throughput genome-scale functional screens and systematic experimental testing of gene function.
| Jennifer A. Doudna | JAMA | 2015
Discusses how advances in DNA sequencing and programmable genome editing could combine to reshape future medicine.
| Maxwell W. Libbrecht and William Stafford Noble | Nature Reviews Genetics | 2015
Reviews machine-learning approaches for extracting biological knowledge from increasingly large and complex genetic and genomic datasets.
Transcriptomics and Functional Genomics
| GTEx Consortium | Science | 2020
The mature GTEx atlas analyzes thousands of tissue samples to reveal widespread genetic control of expression and splicing across the human body.
| Nicole M. Ferraro et al. | Science | 2020
Uses gene expression, allele-specific expression and alternative splicing across tissues to identify rare variants with important functional effects.
| Meritxell Oliva et al. | Science | 2020
Examines how sex influences gene expression and its genetic regulation across dozens of human tissues, adding another layer to functional genomics.
| Sarah Kim-Hellmuth et al. | Science | 2020
Shows how genetic effects on gene expression can differ by cell type and demonstrates why bulk-tissue genomics can conceal important regulatory associations.
| Robin Andersson and Albin Sandelin | Nature Reviews Genetics | 2020
Reviews the genomic features determining enhancer and promoter activity and shows that regulatory elements often possess overlapping transcriptional functions.
| Rory Stark, Marta Grzelak and James Hadfield | Nature Reviews Genetics | 2019
Reviews a decade of RNA-seq development, including advances in differential expression, alternative splicing, single-cell sequencing, RNA structure and translation studies.
| Sandy L. Klemm, Zohar Shipony and William J. Greenleaf | Nature Reviews Genetics | 2019
Reviews genome-wide chromatin accessibility as a means of identifying regulatory DNA and understanding how transcription factors control cellular identity.
| GTEx Consortium | Nature | 2017
The GTEx project linked genetic variation with gene expression across 44 human tissues, providing a major reference for interpreting regulatory variation underlying traits and disease.
| Stefan H. Stricker, Anna Köferle and Stephan Beck | Nature Reviews Genetics | 2017
Describes the transition from simply mapping epigenomes toward experimentally determining which epigenomic features actually regulate genome function.
| Zhong Wang, Mark Gerstein and Michael Snyder | Nature Reviews Genetics | 2009
RNA-seq emerged as a revolutionary sequencing-based method for measuring transcriptomes, revealing gene-expression levels, splice variants and previously unrecognized RNA complexity across entire genomes.
Spatial Genomics and Single-Cell Omics
| Enikő Lázár and Joakim Lundeberg | Nature Reviews Genetics | 2026
Reviews how spatial omics reveals the organization of development and disease by mapping molecular states, cell populations and multicellular niches directly within tissues.
| Cole Trapnell | Nature Reviews Genetics | 2024
Examines statistical approaches for using rapidly expanding single-cell and spatial datasets to infer gene function and biological mechanisms.
| Katy Vandereyken et al. | Nature Reviews Genetics | 2023
Reviews methods that simultaneously measure genomes, epigenomes, transcriptomes, proteins and other molecular features at single-cell and spatial resolution.
| Sebastian Preissl, Kyle J. Gaulton and Bing Ren | Nature Reviews Genetics | 2023
Describes how single-cell epigenomics is being used to identify promoters, enhancers and other cis-regulatory elements in individual cell types.
| Jeffrey R. Moffitt, Emma Lundberg and Holger Heyn | Nature Reviews Genetics | 2022
Surveys spatial profiling technologies that map RNA, DNA and proteins while preserving the physical organization of cells within tissues.
| Sophia K. Longo et al. | Nature Reviews Genetics | 2021
Explains how combining single-cell RNA sequencing with spatial transcriptomics can reveal cellular neighborhoods, tissue architecture and intercellular communication.
| Tim Stuart and Rahul Satija | Nature Reviews Genetics | 2019
Reviews computational approaches for integrating gene-expression, epigenetic, spatial, protein and other data from individual cells.
| Darren J. Burgess | Nature Reviews Genetics | 2019
Highlights technological advances that brought spatial transcriptomics closer to transcriptome-wide analysis at single-cell resolution.
| Darren J. Burgess | Nature Reviews Genetics | 2016
Surveys early spatial transcriptomics approaches and the trade-offs between molecular coverage and spatial resolution.
| Nicola Crosetto, Magda Bienko and Alexander van Oudenaarden | Nature Reviews Genetics | 2015
Early review of technologies capable of measuring RNA while retaining spatial information, anticipating the emergence of spatial genomics and multi-omics.
Epigenomics and Three-Dimensional Genomes
| Wendy A. Bickmore | Nature Reviews Genetics | 2025
Discusses emerging models connecting enhancer-promoter communication with the physical three-dimensional organization of chromosomes.
| Nir Hananya, Shany Koren and Tom W. Muir | Nature Reviews Genetics | 2024
Describes engineered chromatin systems that allow researchers to experimentally test molecular mechanisms underlying epigenetic regulation.
| Magda Bienko | Nature Reviews Genetics | 2023
Describes how development of Hi-C transformed chromosome biology by enabling genome-wide measurement of long-range chromatin interactions.
| Dimple Notani | Nature Reviews Genetics | 2022
Revisits the discovery of enhancers and their subsequent emergence as central components of genome regulation, development and disease.
| Rieke Kempfer and Ana Pombo | Nature Reviews Genetics | 2020
Compares chromosome-conformation and imaging technologies used to map genome architecture and investigate spatial regulation of DNA.
| Olivier Cuvier and Beat Fierz | Nature Reviews Genetics | 2017
Reviews technologies that measure chromatin dynamics from individual molecules through entire genomes and links those dynamics to epigenetic regulation.
| Boyan Bonev and Giacomo Cavalli | Nature Reviews Genetics | 2016
Reviews how chromosomes fold into loops, domains, compartments and territories and how three-dimensional genome structure influences gene expression and development.
| Aaron Taudt, Maria Colomé-Tatché and Frank Johannes | Nature Reviews Genetics | 2016
Examines genetic contributions to epigenomic differences among individuals and their effects on chromatin states and gene expression.
| Authors listed in source | Nature Reviews Genetics | 2013
Reviews statistical and computational approaches for interpreting chromosome-conformation data and reconstructing the three-dimensional organization of genomes.
| Dustin E. Schones and Keji Zhao | Nature Reviews Genetics | 2008
Reviews early genome-wide technologies for mapping histone modifications, nucleosome positioning and other components of the epigenome.
GWAS, Polygenic Risk and Complex Traits
| Iftikhar J. Kullo | Nature Reviews Genetics | 2026
Reviews growing clinical applications of polygenic risk scores along with challenges involving precision, population transferability and physician and patient understanding.
| Authors listed in source | Nature Reviews Genetics | 2025
Examines genome-wide association testing beyond SNPs, emphasizing copy-number variation and other forms of genomic diversity.
| Authors listed in source | Nature Reviews Genetics | 2024
Reviews principles and statistical methods for making polygenic risk scores more transferable across globally diverse ancestry groups.
| Iftikhar J. Kullo et al. | Nature Reviews Genetics | 2022
Experts assess the potential and limitations of polygenic scores for research, prevention, clinical care and equitable precision medicine.
| Ruowang Li et al. | Nature Reviews Genetics | 2020
Explores combining polygenic risk scores with electronic health records to improve disease prediction and personalized prevention.
| Nicholas J. Timpson et al. | Nature Reviews Genetics | 2018
Reviews genetic architecture and how GWAS, exome sequencing and whole-genome sequencing collectively reveal the genetic basis of complex traits.
| Ali Torkamani, Nathan E. Wineinger and Eric J. Topol | Nature Reviews Genetics | 2018
Examines whether aggregating many small genetic effects into polygenic risk scores can provide useful individualized estimates of disease susceptibility.
| Mark I. McCarthy et al. | Nature Reviews Genetics | 2008
Reviews the early successes, methodological lessons and unresolved challenges that emerged as GWAS rapidly expanded.
| Joel N. Hirschhorn and Mark J. Daly | Nature Reviews Genetics | 2005
Anticipates genome-wide association studies as a powerful means of finding common variants contributing to complex traits and diseases.
| William Y. S. Wang et al. | Nature Reviews Genetics | 2005
Examines statistical power, marker density, sample size and disease architecture in the emerging era of genome-wide association studies.
Genome Assembly, Pangenomes and Structural Variation
| Hufsah Ashraf et al. | Nature Reviews Genetics | 2026
Reviews construction and application of pangenome references that capture many haplotypes and reduce biases inherent in single linear references.
| Hyun Joo Ji, Mihaela Pertea and Steven L. Salzberg | Nature Reviews Genetics | 2026
Reviews genome annotation at increasing scale and resolution, including improved identification of genes, transcripts and functional elements.
| Ryan L. Collins and Michael E. Talkowski | Nature Reviews Genetics | 2025
Reviews the diversity, mutational origins and medical consequences of structural variants across human genomes.
| Heng Li and Richard Durbin | Nature Reviews Genetics | 2024
Reviews genome-assembly algorithms in the long-read era and the growing ability to reconstruct complete chromosomes from telomere to telomere.
| Zhi Yu et al. | Nature Reviews Genetics | 2024
Reviews the interplay between inherited germline variation and somatic mutations that arise within individuals over a lifetime.
| Nathan D. Olson et al. | Nature Reviews Genetics | 2023
Reviews modern variant calling and benchmarking as long reads, deep learning, complete genomes and pangenomes extend analysis into difficult genomic regions.
| Bonnie Berger and Yun William Yu | Nature Reviews Genetics | 2023
Explores how computational analysis, rather than sequencing itself, is increasingly becoming the bottleneck in genomics as datasets grow.
| Rachel M. Sherman and Steven L. Salzberg | Nature Reviews Genetics | 2020
Explains why a single reference genome cannot capture human diversity and describes the emergence of species-wide pangenome references.
| Mark J. P. Chaisson, Richard K. Wilson and Evan E. Eichler | Nature Reviews Genetics | 2015
Explains how de novo genome assembly can expose structural and sequence variation that reference-based methods often fail to detect.
| Rasmus Nielsen et al. | Nature Reviews Genetics | 2011
Reviews statistical methods for accurately identifying SNPs and genotypes from next-generation sequencing data.
Clinical, Prenatal and Population Genomics
| Khaled Alabduljabbar et al. | Family Medicine and Community Health | 2026
Describes a model for bringing genomic medicine and precision-health approaches into primary-care practice.
| World Health Organization | WHO | 2026
Describes the World Health Assembly's endorsement of precision medicine and the growing role of genomic and molecular information in equitable health systems.
| Kate Elizabeth Stanley, Bernard Thienpont and Joris Robert Vermeesch | Nature Genetics | 2025
Examines expansion of non-invasive prenatal screening beyond chromosome abnormalities toward broader maternal and fetal genomic and molecular information.
| Monica H. Wojcik et al. | New England Journal of Medicine | 2024
Demonstrates how genome sequencing can identify rare-disease-causing variants missed by previous exome sequencing and conventional genetic testing.
| Lara Andreoli et al. | European Journal of Human Genetics | 2024
Systematically reviews patient, clinician and stakeholder attitudes toward incorporating polygenic risk scores into clinical practice.
| Teri A. Manolio et al. | American Journal of Human Genetics | 2024
Reviews major recent advances in genomic medicine, including population screening, polygenic prediction, actionable variants and clinical sequencing.
| Catherine Rehder et al. | Genetics in Medicine | 2021
Updates technical standards for using targeted panels, exome sequencing and genome sequencing in clinical laboratories.
| Natasha T. Strande et al. | Genetics in Medicine | 2018
Reviews practical complexities encountered when applying standardized variant-interpretation frameworks to Mendelian disease.
| Joris Robert Vermeesch, Thierry Voet and Koenraad Devriendt | Nature Reviews Genetics | 2016
Reviews sequencing-based prenatal and preimplantation genetic diagnosis, including single-cell testing and analysis of fetal DNA.
| Sue Richards et al. | Genetics in Medicine | 2015
Establishes the influential ACMG/AMP framework for classifying sequence variants as pathogenic, likely pathogenic, uncertain, likely benign or benign.
Comparative, Evolutionary and Conservation Genomics
| Paschalia Kapli et al. | Nature Reviews Genetics | 2026
Highlights natural-history collections as an enormous resource for building comparable genomic datasets across large numbers of species.
| Pontus Skoglund and Iain Mathieson | Nature Reviews Genetics | 2026
Reviews how modern and ancient genomic datasets are revealing the timing, intensity and biological targets of natural selection in recent human history.
| Anna E. Dewar, Laurence J. Belcher and Stuart A. West | Nature Reviews Genetics | 2025
Explains why comparative genomics must account for shared ancestry and how phylogenetic approaches improve genome-scale evolutionary analyses.
| Carolyn J. Hogg | Nature Reviews Genetics | 2024
Argues for translating rapidly growing genomic resources into practical management strategies for threatened species and biodiversity.
| Madlen Stange, Rowan D. H. Barrett and Andrew P. Hendry | Nature Reviews Genetics | 2021
Examines how genomic variation supports population resilience, ecosystem functioning and the ability of species to adapt to environmental change.
| Martin F. Breed et al. | Nature Reviews Genetics | 2019
Reviews the potential for genomic data to improve ecological restoration by guiding seed sourcing, genetic diversity and adaptive management.
| Jennifer R. S. Meadows and Kerstin Lindblad-Toh | Nature Reviews Genetics | 2017
Reviews comparative vertebrate genomics as a tool for understanding genome evolution, conserved regulatory elements, traits and human disease.
| Authors listed in source | Nature Reviews Genetics | 2014
Reviews genome-scale approaches for investigating speciation, reproductive isolation, genomic divergence and gene flow.
| Fred W. Allendorf, Paul A. Hohenlohe and Gordon Luikart | Nature Reviews Genetics | 2010
Explores how genome sequencing could transform conservation genetics by revealing diversity, adaptation, migration and population history.
| Abel Ureta-Vidal, Laurence Ettwiller and Ewan Birney | Nature Reviews Genetics | 2003
Early review showing how whole-genome comparisons among animals could reveal conserved sequences and mechanisms of genome evolution.
Agricultural and Synthetic Genomics
| Xinfeng Liu, Bingjie Li and Lingzhao Fang | Nature Reviews Genetics | 2026
Explores how comparative genetics and multi-omics in livestock can inform both precision agriculture and understanding of human traits and disease.
| Joshua S. James et al. | Nature Reviews Genetics | 2025
Reviews the design, construction, delivery and debugging of synthetic genomes and their potential applications in biotechnology, medicine and agriculture.
| Cock van Oosterhout et al. | Nature Reviews Biodiversity | 2025
Examines possibilities for applying genome engineering to biodiversity conservation and restoration while considering ecological and governance challenges.
| Mona Schreiber et al. | Nature Reviews Genetics | 2024
Reviews plant pangenomes and their use in crop improvement, biodiversity research, domestication studies and discovery of useful genetic variation.
| Michel Georges, Carole Charlier and Ben Hayes | Nature Reviews Genetics | 2019
Examines how genomic selection has accelerated genetic improvement in livestock and how multi-omics could further increase breeding efficiency.
| Peter L. Morrell, Edward S. Buckler and Jeffrey Ross-Ibarra | Nature Reviews Genetics | 2012
Reviews how reference genomes, resequencing and genome-wide markers transformed crop domestication research and plant breeding.
| Wilfried Weber and Martin Fussenegger | Nature Reviews Genetics | 2012
Reviews synthetic-biology approaches with emerging applications in diagnostics, therapeutics, vaccines, engineered cells and disease control.
| Ahmad S. Khalil and James J. Collins | Nature Reviews Genetics | 2010
Reviews the transition of synthetic biology from simple engineered gene circuits toward applications in therapeutics, biosensing and biological manufacturing.
| Shankar Mukherji and Alexander van Oudenaarden | Nature Reviews Genetics | 2009
Shows how engineered genetic circuits can serve as experimental tools for understanding biological design principles and gene regulation.
| Steven A. Benner and A. Michael Sismour | Nature Reviews Genetics | 2005
Early review defining synthetic biology as both construction of novel biological systems and a strategy for discovering fundamental principles of genome function.
Microbial and Pathogen Genomics
| Kathryn E. Holt | Nature Reviews Genetics | 2026
Discusses the growing scale of microbial genomics and its importance for understanding antimicrobial resistance across species, environments and ecosystems.
| Oscar Enrique Torres Montaguth et al. | Nature Reviews Microbiology | 2026
Reviews clinical metagenomics for pathogen-agnostic viral diagnosis, outbreak investigation and surveillance of emerging viruses.
| Arthur Kocher, Johannes Krause and Maria A. Spyrou | Nature Reviews Microbiology | 2026
Examines how ancient pathogen genomes reveal the causes, spread and long-term evolution of infectious diseases.
| Alison E. Mather et al. | Nature Reviews Microbiology | 2024
Reviews whole-genome and metagenome sequencing for tracing foodborne pathogens and understanding their ecology across food-production systems.
| Charles Y. Chiu and Steven A. Miller | Nature Reviews Genetics | 2019
Reviews clinical metagenomic sequencing as a broad approach to diagnosing infections without requiring clinicians to specify a pathogen in advance.
| Nature Reviews Genetics Editors | Nature Reviews Genetics | 2019
Surveys the transformative impact of high-throughput genomics on microbiology, pathogen evolution, infectious-disease diagnostics and outbreak surveillance.
| Stephen Baker, Nicholas Thomson, François-Xavier Weill and Kathryn E. Holt | Science | 2018
Reviews genomic evidence showing how major antimicrobial-resistant bacterial lineages arise, adapt and spread internationally.
| Terence S. Crofts, Andrew J. Gasparrini and Gautam Dantas | Nature Reviews Microbiology | 2017
Reviews how genomic and metagenomic technologies reveal antibiotic-resistance genes across pathogens, commensal organisms and environmental microbial communities.
| Jessica M. A. Blair et al. | Nature Reviews Microbiology | 2015
Reviews the molecular mechanisms of antibiotic resistance and how genomics and systems biology improved understanding of their evolution and spread.
| Gerard D. Wright | Nature Reviews Microbiology | 2007
Introduces the antibiotic resistome concept and describes genomes and microbial communities as enormous reservoirs of resistance genes.
Genomic Data, Ethics, AI and Society
| Manfred Kayser | Nature Reviews Genetics | 2026
Reviews how genomics, transcriptomics, epigenomics and microbiome analysis are expanding the information obtainable from forensic biological samples.
| Rasika Venkatesh and Marylyn D. Ritchie | Nature Reviews Genetics | 2026
Reviews artificial-intelligence approaches for integrating genomic information with longitudinal electronic health records for risk prediction and biological discovery.
| Tyler Thomson et al. | Nature Reviews Genetics | 2026
Reviews how artificial intelligence is being applied to CRISPR nuclease, base-editing and prime-editing systems to improve targeting, efficiency and genome-editing design.
| Vasiliki Rahimzadeh et al. | Nature Reviews Genetics | 2025
Examines ethical governance of genomic information stored and analyzed in cloud environments, including privacy, transparency, equity and access.
| World Health Organization | WHO | 2024
Provides global guidance for ethical and equitable collection, access, use and sharing of human genomic data.
| Sondos Mubarak and Mohamed Ashraf | Eastern Mediterranean Health Journal | 2024
Reviews genomic-research ethics in low- and middle-income countries, including informed consent, data security, representation and equitable access to benefits.
| Ben Langmead and Abhinav Nellore | Nature Reviews Genetics | 2018
Reviews cloud computing as an increasingly important infrastructure for storing, analyzing and collaboratively studying enormous genomic datasets.
| Amy L. McGuire, Timothy Caulfield and Mildred K. Cho | Nature Reviews Genetics | 2008
Examines ethical challenges created by whole-genome sequencing, including returning results, implications for relatives and future use of genomic data.
| Jeantine E. Lunshof et al. | Nature Reviews Genetics | 2008
Introduces open-consent approaches developed for personal-genome research and explores changing concepts of genetic privacy.
| Anne Cambon-Thomsen | Nature Reviews Genetics | 2004
Reviews social and ethical questions arising from large-scale biobanks that link biological samples with genomic and health information.
